By G HossainPosted on September 12, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The settlement agreement will extend market exclusivity for AbbVie’s JAK inhibitor in the U.S. until 2037—providing pediatric exclusivity is granted. AbbVie Adds Four Years of Exclusivity to Rinvoq Franchise With Generics Settlement Post navigation Intercept Withdraws Embattled Liver Drug from US MarketMerck To Cut 125 Employees as It Ends UK R&D Work